74184-29-5

Basic information

• Product Name: (9S,10S)-6,6,9-trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-benzo[c]chromene-1,9,10-triol
• CAS NO: 74184-29-5
• Molecular Formula: C₂₁H₃₀O₄
• Molecular Weight: 346.4605
• Mol File: 74184-29-5.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 500.4°C at 760 mmHg
• Flash Point: 256.4°C
• Density: 1.19g/cm³
• Vapor Pressure: 7.8E-11mmHg at 25°C
• Refractive Index: 1.591
• CAS DataBase Reference: (9S,10S)-6,6,9-trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-benzo[c]chromene-1,9,10-triol(CAS DataBase Reference)
• NIST Chemistry Reference: (9S,10S)-6,6,9-trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-benzo[c]chromene-1,9,10-triol(74184-29-5)
• EPA Substance Registry System: (9S,10S)-6,6,9-trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-benzo[c]chromene-1,9,10-triol(74184-29-5)

Safety Data

• Hazardous Substances Data: 74184-29-5(Hazardous Substances Data)

Upstream product

• 1972-08-3 dronabinol 

Relevant articles and documents

Antibody-catalyzed oxidation of Δ9-tetrahydrocannabinol

Marijuana abuse continues to plague society and the lack of effective treatments warrants concern. Catalytic antibodies capable of oxidatively degrading the major psychoactive component of marijuana, Δ9- tetrahydrocannabinol (Δ9-THC), are presented. The antibodies generate reactive oxygen species from singlet oxygen (1O 2*), using riboflavin (vitamin B2) and visible light as the 1O2*source. Cannabitriol was identified as the major degradation product of this reaction, demonstrating the ability of an antibody to catalyze a complex chemical transformation with therapeutic implications for treating marijuana abuse.